Therapeutic Nuclear Medicines Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

Therapeutic nuclear medicine is a pharmaceutical preparation consisting of radioactive substances (radioactive isotopes). Nuclear therapy is aimed at treating cancer, metastatic bone pain and other diseases. The radioactive substances in nuclear medicine can kill cancer tissue, reduce the size of the tumor, and reduce pain.

Therapeutic Nuclear Medicines market size was US$ 1296.2 million and is forecast to 2815.3 million US in 2027, growing at a CAGR of 13% during the 2021-2027.

Segment by Type

• Radium-223
• Lutetium-177
• Iodine-131
• Other

Segment by Application

• Thyroid
• Bone Metastasis
• Lymphoma
• Other

By Company

• Novartis AG
• Bayer
• China Isotope & Radiation
• Q BioMed
• Curium Pharmaceuticals
• Jubilant DraxImage

Scope of the Report

The research study analyzes the global Therapeutic Nuclear Medicines industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Therapeutic Nuclear Medicines Market Report

1. What was the Therapeutic Nuclear Medicines Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of Therapeutic Nuclear Medicines Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Therapeutic Nuclear Medicines Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.